FDA Inspection 1115732 — Elena Santagostino, MD PhD
The FDA completed an inspection of Elena Santagostino, MD PhD on December 20, 2019 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional Details
Clinical Investigator (CI)